Pantheon China Acquisition Corp.
Cash in trust
—
Not yet disclosed
Trust per share
—
Redemption value
IPO
Dec 2006
—
Combination deadline
—
Not disclosed
Filings on record
93
Latest Jan 21, 2016
Overview
Pantheon China Acquisition Corp. is a special purpose acquisition company incorporated in Delaware and registered with the SEC under CIK 0001367209. It completed its initial public offering in Dec 2006. The vehicle is sponsored by Pantheon China. The mandate targets generalist. Deadline lapsed without a deal; trust returned to public shareholders.
“we intend to acquire, as the case may be, will be able to complete the necessary approval, filings and registrations for a proposed business combination.”
Reading the filings
Arithmetic on what Pantheon China Acquisition Corp. has disclosed, written the way a desk would read it. These are observations, not a rating. Nothing here scores the vehicle or implies a view on it.
Underwriting
EarlybirdCapital led the offering. It has been named on 72 SPAC IPOs, book-running 1 of them, and 65.5% of its resolved vehicles closed a deal. The syndicate has no control over whether a sponsor finds a target, but the quality of the book at pricing shapes who ends up holding the units.
Filings per month since the first one. A vehicle that has gone quiet with a deadline ahead is a different proposition from one that is still working.
93 filings in all. 1 in the last three months, against a busiest month of 17.
News on Pantheon China Acquisition Corp.
Last 90 daysNothing in the last 90 days that names this vehicle. We attribute a story only when the release carries the ticker or the registered name, so an empty section means no press release or wire story matched — not that nothing was published. The filings below are the primary record either way.
SEC filing history
Free tier: filings older than 24 hours- REVOKED
REVOKED filing
Accession 9999999997-16-016386
- SC 13D/A
SCHEDULE 13D/A
Accession 0001144204-09-036775
- 4
Statement of changes in beneficial ownership
Accession 0001144204-09-036764
- SC 13D/A
Amended beneficial ownership report (activist)
Accession 0000950123-09-020439
- 4
Statement of changes in beneficial ownership
Accession 0001209191-09-035044
- 8-K
Entry into a material definitive agreement
Items 1.01, 9.01 · Accession 0001144204-09-034126
- 425
Business-combination communication
Accession 0001144204-09-034127
- 10-K/A
10-K/A filing
Accession 0001144204-09-028263
- 10-Q
Quarterly report
Accession 0001144204-09-027459
- SC 13D
Beneficial ownership report (activist)
Accession 0001144204-09-025800
- 10-K/A
10-K/A filing
Accession 0001144204-09-024099
- 10-K
Annual report
Accession 0001144204-09-018044
- 8-K
Entry into a material definitive agreement
Items 1.01, 9.01 · Accession 0001144204-09-016207
- 8-K
Other events
Items 8.01, 9.01 · Accession 0001144204-09-016128
- SC 13G/A
SC 13G/A
Accession 0001193125-09-029627
- SC 13G/A
Amended beneficial ownership report (passive)
Accession 0001193125-09-029337
- SC 13G/A
Amended beneficial ownership report (passive)
Accession 0000948046-09-000025
- SC 13G/A
Amended beneficial ownership report (passive)
Accession 0001011443-09-000288
- SC 13G/A
Amended beneficial ownership report (passive)
Accession 0001193125-09-017258
- UPLOAD
SEC staff comment letter
Accession 0000000000-08-064042
- SC 13G/A
Amended beneficial ownership report (passive)
Accession 0001362310-08-008334
- 3
Initial statement of beneficial ownership
Accession 0001209191-08-066091
- SC 13D
Beneficial ownership report (activist)
Accession 0000950123-08-017675
- 3
Initial statement of beneficial ownership
Accession 0001144204-08-069611
- SC 13D
Beneficial ownership report (activist)
Accession 0001144204-08-069593
- 8-K
Current report
Items 5.03, 9.01 · Accession 0001144204-08-069478
- 8-K/A
8-K/A filing
Item 9.01 · Accession 0001144204-08-069373
- SC 13G/A
Amended beneficial ownership report (passive)
Accession 0001412327-08-000015
- 8-K/A
Entry into a material definitive agreement; Other events
Items 1.01, 8.01, 9.01 · Accession 0001144204-08-068866
- DEFA14A
Additional proxy soliciting material
Accession 0001144204-08-068867
Pro
Track Pantheon China Acquisition Corp. without the delay
Free accounts see this filing history a day late. Pro shows every document minutes after EDGAR publishes it, opens it on EDGAR in one click, and adds the twelve-month deadline calendar.
- Filings live, no 24-hour delay
- One click through to the source document
- Deadline calendar out to 12 months
- CSV export, API and MCP access
Cancel any time. Billed monthly in USD.
Pantheon China Acquisition Corp.: questions answered
What is Pantheon China Acquisition Corp.?
Pantheon China Acquisition Corp. is a special purpose acquisition company incorporated in Delaware and registered with the SEC under CIK 0001367209. It completed its initial public offering in Dec 2006. The vehicle is sponsored by Pantheon China. The mandate targets generalist. Deadline lapsed without a deal; trust returned to public shareholders.
How much does Pantheon China Acquisition Corp. hold in trust?
No trust balance has been disclosed in a filing we have indexed for Pantheon China Acquisition Corp.. For a newly priced IPO this is normal: the figure first appears in the quarterly report after closing.
When must Pantheon China Acquisition Corp. complete a merger?
No combination deadline appears in the filings we have indexed. The date is stated in the charter and repeated in each quarterly report; where our parser could not establish it with confidence we leave it blank rather than infer one.
What happens if Pantheon China Acquisition Corp. does not find a target in time?
The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.
Can I redeem shares in Pantheon China Acquisition Corp., and at what price?
Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.
Is the trust value the same as the share price for Pantheon China Acquisition Corp.?
No. Trust per share is a disclosed, contractual figure: what a redeeming holder receives. The market price is whatever the shares change hands at, which can sit above the trust when a deal is well received or below it when the market doubts one will close. We do not have a current quote for this vehicle, so no spread is shown.
Who sponsors Pantheon China Acquisition Corp., and what is their track record?
Pantheon China is the sponsor entity, part of the Pantheon China franchise. This is the only vehicle we have attributed to that sponsor.
Which banks underwrote the Pantheon China Acquisition Corp. IPO?
EarlyBirdCapital, Legend Merchant. Syndicate membership and role are read from the prospectus cover and the underwriting section.
Is Pantheon China Acquisition Corp. a good investment?
That is not a question this site answers. Pantheon China Acquisition Corp. is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.
Where does this Pantheon China Acquisition Corp. data come from?
Filings Pantheon China Acquisition Corp. submitted to the SEC under CIK 0001367209: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.
Compiled by the SPACListing research desk
Last reconciled Oct 19, 2026
Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.
Read the full methodology · What is in the dataset · Report a correction
SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.
Continue reading
The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.
Pantheon China: the full record
Every vehicle this sponsor has launched, what closed, what liquidated and what is still live.
EarlyBirdCapital in SPACs
Mandates, bookrun credit, deal volume and the outcome of the vehicles it priced.
Generalist SPACs
Every vehicle chasing the same mandate, ranked by cash in trust.
All liquidated spacs
Deadline lapsed without a deal; trust returned to public shareholders.
Deadline calendar
Which sponsors are running out of time, and when the extension votes land.
What is a SPAC?
The structure, the economics and where the risks actually sit.
SPAC glossary
Every term in a blank-check filing, defined the way practitioners use it.
How this data is built
Coverage universe, ingestion, normalisation, lifecycle classification and known limits.